摘要
二十世纪下半叶,合成化学品在各种工业和农业应用中的应用急剧增加,导致由于未受到环境污染而影响生态系统各个营养水平的特定扰动。尽管内分泌干扰化学品(EDCs)如杀虫剂和增塑剂越来越有用,但它们对环境健康的法定影响却令人担忧。 EDCs可以破坏生理稳态,导致发育和生殖异常。临床前动物实验以及流行病学研究都将EDC暴露与代谢综合征,2型糖尿病以及心血管健康等代谢紊乱联系起来。在这里,我们简要回顾一下EDCs对代谢紊乱的法定影响以及它们对环境健康的影响。最后,考虑到这种相互作用的复杂性,已经解决了与EDC诱导的代谢疾病分类作为全球疾病负担的风险因素有关的困难
关键词: 内分泌干扰化学物质,代谢途径,危险因素,全球疾病负担,血管疾病,代谢紊乱。
图形摘要
Current Drug Targets
Title:Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases
Volume: 19 Issue: 9
关键词: 内分泌干扰化学物质,代谢途径,危险因素,全球疾病负担,血管疾病,代谢紊乱。
摘要: The latter half of the twentieth century has witnessed a humongous spurt in the use of synthetic chemicals in a wide variety of industrial and agricultural applications leading to specific perturbations affecting every trophic level of the ecosystems due to unmitigated environmental contamination. Despite the incremental usefulness of endocrine disrupting chemicals (EDCs) such as pesticides and plasticizers, their statutory impact on environmental health is assuming worrisome proportions. The EDCs can disrupt physiological homeostasis resulting in developmental and reproductive abnormalities. Both preclinical animal experiments, as well as epidemiological studies, have correlated EDC exposure with metabolic disorders such as metabolic syndrome, type 2 diabetes as well as cardiovascular health. Here we briefly review the statutory impact of EDCs on metabolic disruption as well as their impact on environmental health. Finally, difficulties pertaining to the categorization of EDC induced metabolic diseases as risk factors for global disease burden have been addressed taking into account the complexity of such interactions.
Export Options
About this article
Cite this article as:
Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases, Current Drug Targets 2018; 19 (9) . https://dx.doi.org/10.2174/1389450119666180514122244
DOI https://dx.doi.org/10.2174/1389450119666180514122244 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomic Profiling of Maternal Serum for Early Risk Analysis of
Preterm Birth
Current Proteomics Circulating Endothelial Progenitor Cells as Biomarkers for Prediction of Cardiovascular Outcomes
Current Medicinal Chemistry PPARγ Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?
Current Hypertension Reviews MRI Contrast Agents: Current Status and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry A Review of Current Treatment Strategies for Varicose Veins
Recent Patents on Cardiovascular Drug Discovery Obstetrical Hemorrhage Review
Current Women`s Health Reviews Osteoprotegerin Positively Regulates Hematopoietic Progenitor Cells
Current Stem Cell Research & Therapy Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review
Reviews on Recent Clinical Trials Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?
Current Pharmaceutical Design Chronic Hepatitis C, Insulin Resistance and Vascular Disease
Current Pharmaceutical Design Modulators of Networks: Molecular Targets of Arterial Calcification Identified in Man and Mice
Current Pharmaceutical Design Endothelial Microparticles: Mediators or Markers of Endothelial Cell Dysfunction?
Current Hypertension Reviews Nitric Oxide and Dietary Factors: Part II Cholesterol, Fat, Amino Acids,Proteins and Carbohydrate
Vascular Disease Prevention (Discontinued) Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Current Pharmaceutical Design Roles of miRNA in Cardiovascular Development and Dysfunction
Current Medicinal Chemistry Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design Heart Failure in South America
Current Cardiology Reviews Processing of Amyloid Precursor Protein as a Biochemical Link Between Atherosclerosis and Alzheimers Disease
Cardiovascular & Hematological Disorders-Drug Targets Editorial [Hot Topic: Carbon Monoxide - A Toxic Gas on the Edge to Clinical Application (Guest Editor: Rene Schmidt)]
Current Pharmaceutical Biotechnology